Prevention of no-reflow/slow-flow phenomenon during rotational atherectomy-A prospective randomized study comparing intracoronary continuous infusion of verapamil and nicorandil

American Heart Journal

Volumn 154, Issue 5, 2007, Pages 994.e1-994.e6

  Matsuo, Hitoshi ^a   Watanabe, Sachiro ^a   Watanabe, Takatomo ^a   Warita, Shunichiro ^a   Kojima, Tai ^a   Hirose, Takeshi ^a   Iwama, Makoto ^a   Ono, Koji ^a   Takahashi, Haruki ^a   Segawa, Tomonori ^a   Minatoguchi, Shinya ^b   Fujiwara, Hisayoshi ^b  

^a GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^b GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICORANDIL; NITRATE; VERAPAMIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG EFFECT; FEMALE; HEART INFARCTION; HEART INJURY; HUMAN; INTRACORONARY INFUSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; Q WAVE; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; ROTATIONAL ATHERECTOMY; ST SEGMENT ELEVATION;

EID: 35448976106     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.07.036     Document Type: Article

References (30)

1. Stertzer S.H., Rosenblum J., Shaw R.E., et al. Coronary rotational ablation: initial experience in 302 procedures. J Am Coll Cardiol 2 (1993) 287-295
2. Ellis S.G., Popma J.J., Buchbunder M., et al. Relation of clinical presentation, stenosis morphology, and operator technique to the procedural results of rotational atherectomy and rotational atherectomy-facilitated angioplasty. Circulation 89 (1994) 882-892
3. Sharma S.K., Kini A., Mehran R., et al. Randomized trial of rotational atherectomy versus balloon angioplasty for diffuse in-stent restenosis (ROSTER). Am Heart J 147 (2004) 16-22
4. Doshi S.N., Kini A., Kim M.C., et al. A comparative study of rotational atherectomy in acute and stable coronary syndromes in the modern era. Am J Cardiol 92 (2003) 1404-1408
5. Abbo K.M., Dooris M., Glazier S., et al. Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol 75 (1995) 778-782
6. Topol E.J., and Yadav J.S. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 101 (2000) 570-580
7. Kotani J., Nanto S., Mintz G.S., et al. Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation 106 (2002) 1672-1677
8. Cohen B.M., Weber V.J., Blum R.R., et al. Cocktail attenuation of rotational ablation flow effects (CARAFE) study: pilot. Cathet Cardiovasc Diagn suppl 3 (1996) 69-72
9. Koch K.C., vom Dahl J., Kleinhans E., et al. Influence of a platelet GPIIb/IIIa receptor antagonist on myocardial hypoperfusion during rotational atherectomy as assessed by myocardial Tc-99m sestamibi scintigraphy. J Am Coll Cardiol 33 (1999) 998-1004
10. Williams M.S., Coller B.S., Vaananen H.J., et al. Activation of platelets in platelet-rich plasma by rotablation is speed-dependent and can be inhibited by abciximab (c7E3 Fab; ReoPro). Circulation 98 (1998) 742-748
11. Hanna G.P., Yhip P., Fujise K., et al. Intracoronary adenosine administered during rotational atherectomy of complex lesions in native coronary arteries reduces the incidence of no-reflow phenomenon. Catheter Cardiovasc Interv 48 (1999) 275-278
12. Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol 63 (1989) 18J-24J
13. IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet 359 (2002) 1269-1275
14. Matsubara T., Minatoguchi S., Matsuo H., et al. Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease. J Am Coll Cardiol 35 (2000) 345-351
15. Matsuo H., Watanabe S., Segawa T., et al. Evidence of pharmacologic preconditioning during PTCA by intravenous pretreatment with ATP-sensitive K+ channel opener nicorandil. Eur Heart J 24 (2003) 1296-1303
16. Matsuo H., Watanabe S., Yasuda S., et al. Myocardial perfusion during transient slow-flow in the patient with old vein graft intervention: assessment by serial measurement of pressure-derived fractional flow reserve and thermodilution-derived coronary flow reserve. Catheter Cardiovasc Interv 60 (2003) 392-398
17. Tsubokawa A., Ueda K., Sakamoto H., et al. Effect of intracoronary nicorandil administration on preventing no-reflow/slow flow phenomenon during rotational atherectomy. Circ J 66 (2002) 1119-1123
18. Ito H., Taniyama Y., Iwakura K., et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 33 (1999) 654-660
19. Iwasaki K., Samukawa M., and Furukawa H. Comparison of the effects of nicorandil versus verapamil on the incidence of slow flow/no reflow during rotational atherectomy. Am J Cardiol 98 (2006) 1354-1356
20. Koch K.C., Radke P.W., Kleinhans E., et al. Mechanisms of myocardial hypoperfusion during rotational atherectomy of de novo coronary artery lesions and stenosed coronary stents: insights from serial myocardial scintigraphy. J Nucl Cardiol 9 (2002) 304-311
21. Hongo M., Takenaka H., Uchikawa S., et al. Coronary microvascular response to intracoronary administration of nicorandil. Am J Cardiol 75 (1995) 246-250
22. Pieper G.M., and Gross G.J. Anti-free-radical and neutrophil-modulating properties of the nitrovasodilator, nicorandil. Cardiovasc Drugs Ther 6 (1992) 225-232
23. Yasu T., Ikeda N., Ishizuka N., et al. Nicorandil and leukocyte activation. J Cardiovasc Pharmacol 40 (2002) 684-692
24. Jaraki O., Strauss W.E., Francis S., et al. Antiplatelet effects of a novel antianginal agent, nicorandil. J Cardiovasc Pharmacol 23 (1994) 24-30
25. Messing M., Van Essen H., Smith T.L., et al. Microvascular actions of calcium channel antagonists. Eur J Pharmacol 198 (1991) 189-195
26. Hjemdahl P., and Wallen N.H. Calcium antagonist treatment, sympathetic activity and platelet function. Eur Heart J 18 Suppl A (1997) A36-A50
27. Taniyama Y., Ito H., Iwakura K., et al. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol 30 (1997) 1193-1199
28. Nichols C.G., Ripoll C., and Lederer W.J. ATP-sensitive potassium channel modulation of the guinea pig ventricular action potential and contraction. Circ Res 68 (1991) 280-287
29. Auchampach J.A., Maruyama M., Cavero I., et al. Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning. Circulation 86 (1992) 311-319
30. Sato T., Sasaki N., O'Rourke B., et al. Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels. J Am Coll Cardiol 35 (2000) 514-518